Cite
Hepatic IRS1 and ß-catenin expression is associated with histological progression and overt diabetes emergence in NAFLD patients.
MLA
Enooku, Kenichiro, et al. “Hepatic IRS1 and SS-Catenin Expression Is Associated with Histological Progression and Overt Diabetes Emergence in NAFLD Patients.” Journal of Gastroenterology, vol. 53, no. 12, Dec. 2018, pp. 1261–75. EBSCOhost, https://doi.org/10.1007/s00535-018-1472-0.
APA
Enooku, K., Kondo, M., Fujiwara, N., Sasako, T., Shibahara, J., Kado, A., Okushin, K., Fujinaga, H., Tsutsumi, T., Nakagomi, R., Minami, T., Sato, M., Nakagawa, H., Kondo, Y., Asaoka, Y., Tateishi, R., Ueki, K., Ikeda, H., Yoshida, H., & Moriya, K. (2018). Hepatic IRS1 and ß-catenin expression is associated with histological progression and overt diabetes emergence in NAFLD patients. Journal of Gastroenterology, 53(12), 1261–1275. https://doi.org/10.1007/s00535-018-1472-0
Chicago
Enooku, Kenichiro, Mayuko Kondo, Naoto Fujiwara, Takayoshi Sasako, Junji Shibahara, Akira Kado, Kazuya Okushin, et al. 2018. “Hepatic IRS1 and SS-Catenin Expression Is Associated with Histological Progression and Overt Diabetes Emergence in NAFLD Patients.” Journal of Gastroenterology 53 (12): 1261–75. doi:10.1007/s00535-018-1472-0.